Agendia To Play Pivotal Role In ISPY-2 Trial For Breast Cancer
Agendia, a world leader in molecular cancer diagnostics, announced it will participate in the highly anticipated I-SPY 2 TRIAL for breast cancer, set to launch at the first of nearly twenty research sites...